Palvella Therapeutics (PVLA) Return on Sales (2014 - 2024)
Palvella Therapeutics (PVLA) reported Return on Sales of 0.0% for Q3 2024, up 1.0% year-over-year from 0.0% in Q4 2023, and up 95.16% on a QoQ basis from 0.0% in Q2 2024.
Palvella Therapeutics (PVLA) has 11 years of Return on Sales data on file, last reported at 0.0% in Q3 2024.
- Quarterly Return on Sales rose 1.0% year-over-year to 0.0% in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 0.0% (up 1.0% YoY) and the FY2021 annual result came in at 0.02%, changed 0.0% from the prior year.
- Return on Sales climbed to 0.0% in Q3 2024 per PVLA's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q2 2023 and bottomed at 0.48% in Q1 2024.
- The 5-year median for Return on Sales is 0.02% (2021), against an average of 0.08%.
- The widest annual swing landed in 2023, when Return on Sales jumped 46 bps; it then sank 40 bps in 2024.
- Tracing PVLA's Return on Sales over 5 years: stood at 0.07% in 2020, then jumped by 66 bps to 0.02% in 2021, then tumbled by 1986 bps to 0.46% in 2022, then surged by 98 bps to 0.01% in 2023, then soared by 99 bps to 0.0% in 2024.
- Per Business Quant, the three latest PVLA Return on Sales figures stand at 0.0% (Q3 2024), 0.0% (Q2 2024), and 0.48% (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.48% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.08% |
| Sep 30, 2022 | -0.46% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.07% |
| Jun 30, 2021 | -0.07% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -0.07% |
| Sep 30, 2020 | -0.04% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -0.02% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.19% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -0.02% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | -0.02% |
| Jun 30, 2017 | -0.05% |
| Mar 31, 2017 | -0.06% |
| Dec 31, 2016 | -0.02% |
| Sep 30, 2016 | -0.08% |
| Jun 30, 2016 | -0.05% |
| Mar 31, 2016 | -0.03% |
| Dec 31, 2015 | 0.07% |
| Sep 30, 2015 | -0.09% |
| Jun 30, 2015 | -0.22% |
| Mar 31, 2015 | -0.17% |
| Sep 30, 2014 | -1.08% |
| Jun 30, 2014 | -0.04% |